Topical VEGF-C/D inhibition prevents lymphatic vessel ingrowth into cornea but does not improve corneal graft survival

9Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Vascular endothelial growth factor-C/D (VEGF-C/D) regulates lymphangiogenesis. Ingrowth of lymphatic vessels is negatively associated with corneal transplantation success. In this study, we therefore analyzed the effect local blockade of VEGF-C/D has on inflamed corneas. We used the murine model of suture-induced neovascularization and subsequent high-risk corneal transplantation. Mice were treated with a VEGF-C/D trap prior to transplantation. Topical inhibition of VEGF-C/D significantly reduced lymphatic vessel ingrowth, but increased Macrophage numbers in the cornea. Furthermore, corneal transplantation success was not improved by the topical application of the compound. This study demonstrates that local VEGF-C/D inhibition is insufficient to increases corneal transplantation success, likely due to interaction with immune cells.

Cite

CITATION STYLE

APA

Salabarria, A. C., Koch, M., Schönberg, A., Zinser, E., Hos, D., Hamdorf, M., … Bock, F. (2020). Topical VEGF-C/D inhibition prevents lymphatic vessel ingrowth into cornea but does not improve corneal graft survival. Journal of Clinical Medicine, 9(5). https://doi.org/10.3390/jcm9051270

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free